Author name: andrewshd

Daily foot temperature monitoring leads to fewer hospitalizations, amputations and more

New research examining patients with healed diabetic foot ulcers revealed that daily foot temperature monitoring can result in lower rates of hospitalization and foot ulcer recurrence in high-risk patients, according to a study in BMJ Open Diabetes Research & Care. The study used Podimetrics SmartMats to take the temperature of participants’ feet and to scan […]

Daily foot temperature monitoring leads to fewer hospitalizations, amputations and more Read More »

Industry Voices—Teladoc-Livongo merger means virtual care will finally reach the most vulnerable patients

There have been serious questions about whether the recent boom in virtual care is just a blip. | The recent announcement that Teladcoc and Livongo are merging sends a powerful signal about where virtual care can go. Together, they can combine Teladoc’s large roster of providers who specialize in one-on-one virtual interactions with Livongo’s large-scale

Industry Voices—Teladoc-Livongo merger means virtual care will finally reach the most vulnerable patients Read More »

Empirical Spine Completes Enrollment in Pivotal IDE Clinical Trial Studying LimiFlex in Degenerative Spondylolisthesis — Empirical Spine

Empirical Spine, Inc., maker of the LimiFlex Paraspinous Tension Band, today announced completion of enrollment in its U.S. IDE trial studying the use of LimiFlex with a decompression for patients suffering from degenerative spondylolisthesis with lumbar spinal stenosis. The trial compares outcomes of patients who receive either LimiFlex or transforaminal lumbar interbody fusion (TLIF) after

Empirical Spine Completes Enrollment in Pivotal IDE Clinical Trial Studying LimiFlex in Degenerative Spondylolisthesis — Empirical Spine Read More »

Channel Medsystems® Receives FDA Approval of its Latest Cerene® Cryotherapy Device for the Treatment of Heavy Menstrual Bleeding in the Office Setting

Next-generation technology enhances ease-of-use for physicians and streamlines manufacturability The Company is targeting limited market introduction in Q42020 and commercial launch of the Cerene® Device in the first half of 2021 Emeryville, California, July 21, 2020 – Channel Medsystems® (“Channel”), a company dedicated to bringing innovation to the delivery of women’s healthcare, today announced that

Channel Medsystems® Receives FDA Approval of its Latest Cerene® Cryotherapy Device for the Treatment of Heavy Menstrual Bleeding in the Office Setting Read More »

VentFree™ Respiratory Muscle Stimulator receives FDA Emergency Use Authorization for Use During COVID-19 Pandemic — Liberate Medical

Potential to reduce ventilation duration and increase the availability of ventilators CRESTWOOD, KY, 4th May 2020 – Liberate Medical today announced that it has received Federal Drug Administration (FDA) Emergency Use Authorization for its VentFree™ Respiratory Muscle Stimulator, intended to be used to reduce disuse atrophy of the abdominal wall muscles, which may reduce the

VentFree™ Respiratory Muscle Stimulator receives FDA Emergency Use Authorization for Use During COVID-19 Pandemic — Liberate Medical Read More »

First Thoraguard Study Completed at Stanford University Medical Center –

Latest Guidelines to Enhance Patient Recovery after Cardiac Surgery Strongly Recommend: Maintenance of Chest Tube Patency to Prevent Complications OMAHA, Neb. – January 21, 2020 – Centese, Inc. today announced completion of the first clinical study of its Thoraguard® digital drainage system used in cardiac surgery at Stanford University Medical Center. Thoraguard is the first

First Thoraguard Study Completed at Stanford University Medical Center – Read More »

Cerene® Cryotherapy Device Recognized in Popular Science’s 2019 “Best of What’s New” Awards

Emeryville, California, December 18, 2019 — Channel Medsystems®, a company dedicated to bringing innovation to the delivery of women’s healthcare, today announced that its Cerene® Cryotherapy Device has received one of Popular Science’s Best of What’s New Awards for 2019. The Cerene® Cryotherapy Device was recognized for offering a new, minimally invasive alternative for the

Cerene® Cryotherapy Device Recognized in Popular Science’s 2019 “Best of What’s New” Awards Read More »

Empirical Spine Completes Investigational Arm Enrollment In Pivotal IDE Clinical Trial Studying LimiFlex In Degenerative Spondylolisthesis

Empirical Spine, Inc., maker of the LimiFlex Paraspinous Tension Band, today announced completion of enrollment in the investigational arm of its U.S. IDE trial studying the use of the LimiFlex with a decompression for patients suffering from degenerative spondylolisthesis with lumbar spinal stenosis. The trial compares outcomes of patients who receive either LimiFlex or transforaminal

Empirical Spine Completes Investigational Arm Enrollment In Pivotal IDE Clinical Trial Studying LimiFlex In Degenerative Spondylolisthesis Read More »

Liberate Medical Announces CE Marking for its VentFree™ Respiratory Muscle Stimulator — Liberate Medical

CRESTWOOD, KY, 21st October 2019 – Liberate Medical, a medical device company developing novel non-invasive electrical muscle stimulation devices to help patients with pulmonary conditions, today announced that it has received CE marking for its VentFree™ Respiratory Muscle Stimulator and ISO 13485 certification for its quality management system. The VentFree stimulator applies proprietary non-invasive electrical

Liberate Medical Announces CE Marking for its VentFree™ Respiratory Muscle Stimulator — Liberate Medical Read More »

Procyrion Names Av Edidin, Ph.D., as Senior Vice President of Development and Manufacturing

Houston, TX (August 6, 2019) – Procyrion, Inc., a clinical-stage medical device company developing the Aortix™ system, a percutaneous blood pump initially targeted for treating patients with heart failure and worsening kidney function (cardiorenal syndrome), announced the appointment of Av Edidin, Ph.D., as Senior Vice President of Development and Manufacturing. In this role, Edidin will

Procyrion Names Av Edidin, Ph.D., as Senior Vice President of Development and Manufacturing Read More »